Objective. Previous studies have suggested that metabolic syndrome is associated with osteoarthritis (OA). However, analyses have often not included adjustment for body mass index (BMI) and have not addressed whether levels of individual metabolic syndrome components are related to OA. This study was undertaken to examine the relationship of metabolic syndrome and its components with radiographic and symptomatic knee OA.
Objective. Previous studies have suggested that metabolic syndrome is associated with osteoarthritis (OA). However, analyses have often not included adjustment for body mass index (BMI) and have not addressed whether levels of individual metabolic syndrome components are related to OA. This study was undertaken to examine the relationship of metabolic syndrome and its components with radiographic and symptomatic knee OA.
Methods. Framingham Study subjects were assessed for OA in 1992-1995 and again in [2002] [2003] [2004] [2005] . Near the baseline visit, subjects had components of metabolic syndrome assessed. We defined incident radiographic OA as present when a knee without radiographic OA at baseline had a Kellgren/Lawrence grade of ‡2 at followup, and defined incident symptomatic OA as present when a knee developed the new combination of radiographic OA and knee pain. After excluding knees with prevalent OA at baseline, we tested the relationship of metabolic syndrome according to the National Cholesterol Education Program Adult Treatment Panel III criteria and its components with the risk of incident radiographic OA and symptomatic OA before and after adjusting for BMI using the risk ratio from a binary regression with generalized estimating equations.
Results. A total of 991 subjects (55.1% women) with a mean age of 54.2 years were studied, and 26.7% of men and 22.9% of women had metabolic syndrome. Metabolic syndrome and many of its components were associated with both incident radiographic OA and symptomatic OA, but after adjustment for BMI, almost all of these associations became weak and nonsignificant. An association of high blood pressure, especially diastolic pressure, with OA outcomes persisted in both men and women.
Conclusion. After adjustment for BMI, neither metabolic syndrome nor its components were associated with incident OA. There may be an association between OA and high blood pressure that needs further study.
Metabolic syndrome (1, 2) , whose elements include central obesity, dyslipidemia, impaired fasting glucose, and hypertension, increases the risk of cardiovascular disease (3) and mortality (4) . Recent work has focused on identifying the relationship of particular components of metabolic syndrome with diseases to better understand its influence on disease pathogenesis (3) .
In the musculoskeletal field, there has been considerable interest in the association of metabolic syndrome with osteoarthritis (OA). Central obesity, a component of metabolic syndrome, is related to body mass index (BMI), a well-known risk factor for knee OA (5) . Other components of metabolic syndrome may affect the occurrence of OA through low-grade inflammation, by altering the microvasculature of subchondral bone, or by causing neuromuscular impairment (6, 7) .
Previous studies have suggested a strong and consistent relationship of metabolic syndrome with an increase in knee OA before adjustment for BMI (8) (9) (10) (11) (12) (13) . After adjusting for BMI or body weight, especially as a continuous variable, most of the positive findings on metabolic syndrome and OA have weakened (8, 11, 12) , while some, especially findings regarding the number of metabolic syndrome components and OA, have persisted (9, 14) . In studies of individual components of metabolic syndrome, central obesity has been the component most frequently associated with knee OA (8, (10) (11) (12) 14, 15) , and in some studies, this relationship has persisted even after adjusting for BMI (11, 13) . Hypertension, especially high diastolic blood pressure, was related to knee OA in some studies (9, 10, 13, 16) but not others (8, 11) .
BMI (and body weight) confer a loading effect both directly on the joint and by causing an increase in muscle force across the joint to accommodate this increased load (5) . In animal models, increased weight and other causes of increased focal load across the joint (malalignment; meniscal tear) all strongly increase OA risk (17) . Thus, some measure of obesity-related load must be adjusted for when evaluating the effect of metabolic syndrome and its components. Further, there is a strong relationship between central obesity and overall BMI, such that conventional regression adjustment for BMI may be insufficient to evaluate the independent effect of central obesity.
Prior studies have almost all been crosssectional, with the exception of Japanese and Swedish studies with radiographic knee OA as the outcome and a study following up persons with OA for hip or knee replacement (9, 11, 13) . Few prior studies focused on the occurrence of symptomatic knee OA.
Metabolic syndrome and its relation to heart disease has been a major focus of the Framingham Heart Study, and components of metabolic syndrome have been carefully assessed. Metabolic syndrome is defined by dichotomizing these components, but dichotomizing disease risk factors may compromise power and limit the ability to detect the threshold effect of risk factors (18) . Using data from the Framingham OA Study, a substudy of the Heart Study, we examined the longitudinal relationship of metabolic syndrome and its components with radiographic and symptomatic knee OA.
PATIENTS AND METHODS
Study design and subjects. Subjects were recruited from the Framingham Offspring Cohort, which consists of the descendants of the original Framingham Heart Study cohort and their spouses. The OA study focused on surviving members of the Offspring Cohort whose parents, members of the original Framingham cohort, had participated in an OA study and their spouses. These subjects were invited to participate in the OA study in 1992-1995 (baseline visit), and came back for a follow-up visit in 2002-2005 (19) . We included subjects who were 40 years and older at baseline because the incidence of knee OA increases dramatically after age 50 (20) . The study was approved by the Boston University Medical Center Institutional Review Board. All participants provided written informed consent.
Metabolic syndrome. Since specific family members of the original cohort were asked to come in for an examination for the OA Study after exam 5 of the Offspring Cohort (which took place in 1990-1993), the assessment of metabolic syndrome occurred a year or so before the OA examination. Participants in the Offspring Cohort fasted overnight and had plasma samples taken for the measurement of glucose and lipids, answered questionnaires about sociodemographic and lifestyle characteristics, and underwent a physical examination. Plasma glucose was measured in fresh specimens with a hexokinase reagent kit (A-gent glucose test; Abbott). Glucose assays were run in duplicate; the intraassay coefficient of variation was 3%. The fasting plasma total cholesterol and plasma triglyceride levels were measured enzymatically, and the highdensity lipoprotein (HDL) cholesterol fraction was measured after precipitation of low-density lipoprotein (LDL) cholesterol and very low-density lipoprotein cholesterol with Dextran sulfate-magnesium (21) . LDL cholesterol was estimated indirectly when triglyceride levels were ,4.52 mmoles/liter (22) . The Framingham laboratory participates in the lipoprotein cholesterol laboratory standardization program administered by the Centers for Disease Control and Prevention in Atlanta, Georgia (23) . Waist circumference was measured as part of the physical examination. Blood pressure was measured twice after subjects had been seated for at least 5 minutes, and the average of the 2 measurements was calculated.
We classified subjects as having metabolic syndrome according to the National Cholesterol Education Program Adult Treatment Panel III (ATP III) criteria (24) . Subjects were considered to have metabolic syndrome if they met at least 3 of the following 5 criteria: 1) abdominal obesity (waist circumference $102 cm [$40 inches] in men and $88 cm [$35 inches] in women), 2) high triglyceride levels ($150 mg/ dl), 3) low HDL cholesterol (,40 mg/dl in men and ,50 mg/dl in women), 4) high blood pressure (systolic blood pressure $130 mm Hg or diastolic blood pressure $85 mm Hg or treatment for high blood pressure), and 5) high fasting glucose ($110 mg/dl or diagnosis of diabetes). We also defined metabolic syndrome using modified ATP III criteria, in which high fasting glucose is based on the cut point of $100 mg/dl suggested by the American Diabetes Association (25) .
Knee radiographic and pain assessment. At baseline and follow-up, bilateral weight-bearing anteroposterior (AP) knee radiographs were obtained using a fixed-flexion approach, and lateral view radiographs were obtained using a validated protocol (26) . Longitudinal knee radiographs were read by a musculoskeletal radiologist (PA) and a rheumatologist. If there was a disagreement as to whether the knee had radiographic OA, the reading was adjudicated by a panel of 3 readers, including the 2 who read all films and a third reader (DTF). A consensus reading was reached when at least 2 of 3 readers agreed.
The Kellgren/Lawrence grade was determined using AP view radiographs, and joint space narrowing and osteophytes were scored on lateral view radiographs. A knee was defined as having radiographic OA in the tibiofemoral joint if it had a Kellgren/ Lawrence grade of $2 on the AP view, and as having radiographic OA in the patellofemoral joint if it had any osteophyte grade of $2, or any osteophyte grade of $1 plus a joint space narrowing grade of $2 in the patellofemoral joint on the lateral view (27) .
Subjects were asked "on most days do you have pain, aching or stiffness in your knee" for each knee at both baseline and follow-up visits. Subjects were considered to have symptomatic knee OA if they had both knee pain and radiographic OA in either tibiofemoral or patellofemoral joint on radiographs.
Covariates. We used data from the Offspring examination on covariates including age, sex, educational attainment, current smoking, physical activity (28) , and alcohol consumption ($1 drink/week). Height and weight were measured, and BMI was calculated as weight in kilograms divided by the square of height in meters (kg/m 2 ). Statistical analysis. Since differential association by sex was observed between some components of metabolic syndrome and prevalent radiographic knee OA in a previous study (15) , we performed sex-specific analyses. Baseline characteristics were explored among subjects with and those without metabolic syndrome prior to all analyses. We also examined the correlation of continuous measurements used to define metabolic syndrome with BMI and body weight.
Metabolic syndrome and incident radiographic OA. Among knees without radiographic OA in both tibiofemoral and patellofemoral joints at baseline, incident radiographic OA was defined as the development of radiographic OA in either tibiofemoral or patellofemoral joint or knee replacement at the follow-up visit. For each exposure at baseline, i.e., metabolic syndrome (yes versus no) and each of its 5 components (yes versus no), we used the risk ratio from a binary regression model to estimate its association with incident radiographic OA. Generalized estimating equations were used to control for the correlation between 2 knees in a subject. We adjusted for age, education level, current smoking, alcohol consumption, and physical activity level in the analysis. To show whether obesity was the main confounding factor to the association of interest, we further adjusted for BMI in another model, and adjusted for body weight instead of BMI in a third model.
To explore whether there was a dose-response relationship between the severity of metabolic syndrome and incident radiographic OA, we used the number of components (1, 2, 3, and 4-5 versus 0) and sex-specific quartiles of each continuous measurement in the definition of metabolic syndrome (2nd-4th quartiles versus the lowest quartile) as exposures. We used the binary regression models described above to assess the association between each severity exposure and incident radiographic OA. If the results suggested a doseresponse relationship, we used the median of continuous measurement in each quartile as continuous exposure to test for a linear trend.
Since waist circumference is highly correlated with BMI and body weight, we used the residual of waist circumference as one way to control for weight-related confounding. The residual of waist circumference was the difference between the observed and expected value from a linear regression model with waist circumference as the dependent variable and BMI as the independent variable in each sex. We classified the BMI-adjusted residual into sex-specific quartiles. Then we replaced BMI with body weight to get the weight-adjusted residual of waist circumference and repeated the analysis. Metabolic syndrome and incident symptomatic OA. Among knees without symptomatic OA at baseline, incident symptomatic OA was defined as the development of symptomatic OA or knee replacement by the time of the follow-up visit. We used the same method as described above to assess the association between each baseline exposure and incident symptomatic OA.
RESULTS
Subject characteristics. Among 1,083 subjects with longitudinal radiograph reading in the Framingham OA Study, 4 subjects with metabolic syndrome not assessed, 55 subjects age ,40 years, and 33 subjects with bilateral radiographic OA at baseline were excluded. The mean 6 SD age of the 991 remaining subjects was 54.2 6 8.1 years at baseline, 55.1% were women, 26.7% of the men and 22.9% of the women had metabolic syndrome according to the ATP III criteria, and 34.2% of the men and 25.1% of the women had metabolic syndrome according to the modified ATP III criteria. Subjects with metabolic syndrome were older, less likely to drink alcohol or have a college education, and had a higher BMI compared with those without metabolic syndrome, especially among women (Table 1) . BMI and body weight were strongly correlated with waist circumference (Pearson's correlation coefficient 5 0.87-0.88 in Table 2 . Metabolic syndrome, its components, and incident radiographic knee OA* 
4).
Metabolic syndrome and incident radiographic OA. Among the knees without radiographic OA at baseline, the incidence of radiographic OA was 9.8% (78 of 800 knees) in men and 10.5% (105 of 1,003 knees) in women. After adjusting for age, education, smoking status, alcohol consumption, and physical activity level, metabolic syndrome, abdominal obesity, and low HDL were associated with an increased incidence of radiographic OA among men (Table 2 ). Among women, abdominal obesity and high blood pressure were associated with incident radiographic OA, but metabolic syndrome was not. After adjusting for BMI or body weight, none of these associations remained significant.
As with metabolic syndrome, the number of metabolic syndrome components was associated with the incidence of radiographic OA before adjustment for BMI or body weight, especially in men, but the association was markedly attenuated and no longer significant when we adjusted for BMI or weight. Increasing waist circumference was associated with an increased incidence of radiographic OA in both sexes, but the trend did not remain after adjusting for either BMI or body weight, and this null association was confirmed by using the residual of waist circumference as exposure (Figure 1 ). The associations of both high systolic blood pressure and high diastolic blood pressure with radiographic OA diminished greatly and became nonsignificant after adjustment for weight or BMI (Table 2 and Figure 1 ). Even so, women with diastolic blood pressure in the highest quartile tended to have a higher incidence of radiographic OA than women with diastolic blood pressure in the lowest quartile (Figure 1) .
Metabolic syndrome and incident symptomatic OA. Among knees without symptomatic OA at baseline, the incidence of symptomatic OA was 6.3% in men (53 of 837) and 7.2% in women (75 of 1,037). Metabolic syndrome was not associated with incident symptomatic OA in men either before or after adjusting for BMI or weight. The association between metabolic syndrome and incident symptomatic OA was observed in women before adjustment but disappeared after controlling for weight-related confounding (Table 3 ). The association † Adjusted for age, education, smoking status, alcohol consumption, and physical activity level. ‡ Adjusted for age, education, smoking status, alcohol consumption, physical activity level, and body mass index. § Adjusted for age, education, smoking status, alcohol consumption, physical activity level, and body weight.
of abdominal obesity and high blood pressure with incident symptomatic OA among men and women became weaker and not statistically significant after adjusting for BMI or body weight (Table 3 and Figure 2 ). Before adjusting for BMI or weight, a trend toward an increase in incident symptomatic OA with the number of metabolic syndrome components was observed among men and remained after adjusting for BMI or body weight for up to 3 components (weightadjusted relative risk 5 1.0, 2.1, 3.2, 2.1, and 2.1 for having 0 to 4 components, respectively, according to ATP III criteria). The trend for number of components and incident symptomatic OA observed in women disappeared after adjusting for BMI or body weight.
Before adjustment for BMI or weight, a higher incidence of symptomatic OA was observed among both men and women with higher waist circumference, systolic blood pressure and diastolic blood pressure quartile, and among women with higher triglyceride levels ( Figure 2) . The trend for waist circumference diminished greatly and became nonsignificant after adjusting for BMI or body weight (Table 3 and Figure 2 ). The trend was attenuated and became nonsignificant for systolic blood pressure quartiles (weight-adjusted P for trend 5 0.082 in men and 0.162 in women), but remained for diastolic blood pressure quartiles (weight-adjusted P for trend 5 0.053 in men and 0.026 in women) after adjusting for BMI or weight. On the other hand, subjects in higher fasting blood glucose quartiles tended to have a lower incidence of symptomatic OA after adjusting for weight-related confounders (P for linear trend 5 0.044 in men and 0.080 in women) (Figure 2 ).
DISCUSSION
Before adjustment for BMI and body weight, metabolic syndrome was associated with an increased incidence of radiographic OA in men and increased incidence of symptomatic OA in women, while the association between the number of components of metabolic syndrome and incident OA was consistent in both sexes and for both radiographic OA and symptomatic OA. After controlling for BMI or weight, the associations of these measures with OA were all markedly attenuated and almost all were no longer significant. Only high diastolic blood pressure remained associated with an increased incidence of symptomatic OA in both men and women after adjusting for body weight.
The strong correlation between the degree of abdominal obesity and BMI or body weight could make it hard to separate the effects of these risk factors in multivariate models. We computed residuals of waist circumference by removing the variation caused by BMI or body weight and assessed the relationship between waist circumference residual and OA. This tended to nullify any association observed (Figures 1 and 2 ). This method showed that abdominal obesity, BMI, and body weight are likely to be measures of the same potential factor.
High blood pressure is another metabolic syndrome component that has been associated with OA in previous studies before adjusting for BMI (9, 10, 13, 16) , and some studies also reported this association after adjusting for BMI (9, 13, 16 ). While we found that diastolic blood pressure was related to incident symptomatic OA even after adjustment for BMI, the relationship between systolic blood pressure and incident symptomatic OA was nearly significant also, suggesting that both might be related to symptomatic OA. Any crosssectional analysis of this relationship would be challenging to interpret since treatment for symptomatic OA includes nonsteroidal antiinflammatory drugs, which can raise blood pressure.
Although symptomatic knee OA is the form of OA that affects quality of life, it has not been as well studied as radiographic OA in terms of its relationship to metabolic syndrome. There is evidence of a role of inflammatory mediators in nociception and pain in arthritis (29) . People with metabolic syndrome, which is accompanied by systemic inflammation, may have higher levels of pain for the same severity of structural OA (13, 29) . The definitions of symptomatic OA in previous studies were inconsistent, including selfreported OA (15) , clinical OA (12) , and severe symptomatic OA as assessed by knee replacement as the outcome (11) . The findings from these studies were also inconsistent. Our study was the first to define symptomatic OA based on both radiographs and knee symptoms and using incident symptomatic OA as the outcome.
After adjustment for BMI, we also found, surprisingly, an inverse association between fasting blood sugar and OA, especially symptomatic OA. In several previous studies, diabetes and elevated blood glucose levels were reported to be positively associated with OA and joint replacement (7) . However, in the Multicenter OA Study, investigators reported no association of diabetes with incident OA in men, whereas in women, the presence of diabetes and an increase in insulin resistance protected against OA onset after adjusting for BMI (30) . Given the inconsistent findings, the relationship between blood sugar and knee OA needs further study.
Our study has strengths and limitations. Strengths include the use of a longitudinal sample with components of metabolic syndrome characterized by state-of-the-art methods. We were able to test different levels of the components of metabolic syndrome rather than just dichotomizing them. We carried out the first attempt to examine the independent effect of central obesity on OA by using the residual approach for adjustment for collinear measures.
Among the limitations of the present study, we have no data to account for change in metabolic syndrome and its components during the 10-year follow-up period, so the exposures were susceptible to misclassification. Metabolic syndrome is a risk factor for several disabling or fatal diseases, so subjects with metabolic syndrome were more likely to be lost to follow-up and this could introduce bias. Further, since we did not know the date of onset of symptomatic OA, we could not adjust for competing risks of death. While metabolic syndrome increases the risk of death, this would bias our results only if the combination of incident OA and metabolic syndrome increased mortality risk more than metabolic syndrome alone, and in the Framingham Study, we have found no association of OA with overall mortality risk in hand OA (31) . Even if symptomatic knee OA were associated with enhanced mortality, this is not likely to be true for new-onset disease, and increases in OA mortality risk seen in other studies are small and would be unlikely to confound our findings (32) . Also, larger numbers of incident OA cases may have led us to identify blood pressure as a significant risk factor for OA, given that our weight-adjusted analysis suggested a persistent association of OA risk with blood pressure. Most of our incident cases were knees with tibiofemoral OA, which limited our ability to examine whether risk for patellofemoral and tibiofemoral OA differed.
In conclusion, this study revealed that metabolic syndrome, the number of its components, and individual components, such as central obesity, are associated with incident knee OA but not independent of BMI and body weight. Incident symptomatic knee OA occurred more frequently with an increase in blood pressure, an association that needs further exploration.
